Clinical resistance associated with a novel <i>MAP2K1</i> mutation in a patient with Langerhans cell histiocytosis

David O. Azorsa(University of Arizona), R.J. Arceci(University of Arizona)
Pediatric Blood & Cancer
May 16, 2018
Cited by 24


Related Papers